Supplements

Vitamin K2 supplementation changed several markers of bone turnover, including osteocalcin and its undercarboxylated form. Another marker, NTX, did not change significantly, and the clinical meaning of the small CTX reduction was uncertain. This is evidence about laboratory measurements in postmenopausal osteoporosis, with bone-density and fracture benefits still unconfirmed by the abstract.

Keep in mind: The abstract does not provide comparator details, treatment duration, or units for the marker effects. It calls for longer-term studies to establish clinical benefits.

The review reports favorable pooled results for fat-free mass, muscle size and strength when multi-ingredient protein supplements were combined with exercise. Fat mass, body-fat percentage, waist circumference and functional performance did not show statistically significant effects. Because the abstract does not describe the comparison conditions or supplement ingredients, the added value of the combined programs remains difficult to judge.

Keep in mind: The abstract omits control conditions, supplement formulations and an overall intervention-duration range. It also provides limited detail for assessing the reported subgroup differences.

The review reports favorable findings for fasting blood glucose and blood lipids, particularly in diabetes and metabolic syndrome. It also describes possible changes in insulin resistance, antioxidant capacity and blood pressure. These are metabolic measurements; the abstract does not establish fewer complications, better quality of life or benefits for people without metabolic disease.

Keep in mind: The abstract supplies no pooled effect sizes, confidence intervals, quality-assessment results or adverse-event findings. The size, certainty and safety of the reported changes remain unclear.

Fish oil was linked to greater reductions in inflammatory blood markers and improved insulin sensitivity compared with the control oil in this small trial. Hospital stays did not differ significantly. These laboratory changes do not establish faster recovery or better overall outcomes, and the authors caution that the findings cannot be generalized.

Keep in mind: The authors explicitly limit generalizability because of the small sample. The abstract reports no confidence intervals for the main comparisons and does not establish whether the blood-marker changes were meaningful to patients.

The pooled trials reported improvements in pelvic pain, menstrual pain and pain during sex, alongside a reduction in a blood marker of oxidative stress. Overall pain and clinical pregnancy did not show statistically significant improvement. The findings suggest different results for different endpoints, without establishing broad pain relief or a fertility benefit.

Keep in mind: The abstract does not describe comparison treatments, follow-up times or confidence intervals. It combines varied antioxidants and reports differences by treatment type, disease stage and duration, limiting conclusions about any individual option.

Fish oil recipients had less muscle soreness than placebo recipients at the later soreness comparison. The abstract also describes recovery of strength measures within each group, but those patterns alone do not establish a between-group advantage. The findings suggest a limited soreness benefit under this exercise protocol, with its size left unclear.

Keep in mind: The abstract does not report the fish oil dose, supplementation schedule, or size of the soreness difference. Its small sample and short follow-up limit interpretation.

The review describes possible cognitive benefits from several natural compounds, but results varied by compound and study design. Curcumin and Melissa officinalis had limited effects, while resveratrol produced mixed findings and some side effects. The abstract does not establish which products meaningfully help people with Alzheimer's disease or mild cognitive impairment.

Keep in mind: The studies differed substantially in design and quality. The abstract provides no effect sizes, cognitive test results, or comparator details, so it cannot establish the magnitude or practical importance of any benefit.

The extract group had better knee symptom and function results than the placebo group, but SF-36 questionnaire scores did not change significantly. This is a finding about a particular product in the study’s narrowly described population. It does not establish that other Boswellia products work similarly or that benefits continue after treatment.

Keep in mind: The abstract does not give the extract dose or clearly identify whether numerical symptom changes are within-group changes or placebo-adjusted differences. Its description of participants as having no or mild osteoarthritis is also imprecise.

In generally healthy adults who felt stressed, a blend of plant extracts, magnesium and chromium improved some mood, anxiety and cognitive test results in a placebo comparison. Cognitive findings were less consistent without a multitasking stressor. The abstract reports no sleep results, despite measuring sleep, and does not establish broader or lasting benefits.

Keep in mind: The analysed sample was small. The abstract does not explain the missing participant data or report effect sizes for the main outcomes, limiting judgments about how large or useful the reported changes were.

The review found higher cognitive-function scores with melatonin in adults who already had cognitive impairment. However, the abstract does not identify the scoring scale or the comparison treatments, making the clinical meaning hard to judge. Its subgroup findings do not establish an optimal administration time or treatment length, and they do not justify general use.

Keep in mind: The abstract omits the cognitive scale, confidence intervals and detailed safety results. It therefore cannot establish a clinically meaningful gain or adequately support its broad safety claim.

The review reports fewer deaths from any cause in the turmeric groups, and the authors rated that evidence as moderately certain. This finding concerns turmeric products used alongside standard care for people already ill with COVID. It does not establish the effect of ordinary dietary turmeric or support claims about preventing infection.

Keep in mind: This abstract-based account cannot clarify the mortality comparators or follow-up periods. Several trials were judged at high risk of bias, and the authors call for larger, higher-quality studies to confirm the findings.

The pooled evidence did not show a statistically significant improvement in short-term mortality, deaths during hospitalization or the other clinical outcomes assessed. This does not prove that vitamin C has no effect, but it leaves a treatment benefit unestablished. The abstract also provides insufficient detail to identify effects of particular dosing or delivery approaches.

Keep in mind: This abstract-based summary cannot identify the comparator regimens, doses or routes used. Evidence quality ranged from very low to moderate, and most studies had low or unclear risk of bias.

Nano-curcumin improved several liver-enzyme measurements relative to placebo, but the trial did not find a significant advantage for liver scarring or fat accumulation. Changes in blood markers therefore should not be read as evidence that fibrosis was reversed. The findings concern a short trial in adults with established fatty-liver-related fibrosis.

Keep in mind: The abstract does not provide effect magnitudes or confidence intervals for the main outcomes. The absence of significant differences does not establish equivalence, and lasting benefits remain uncertain.

The review found triglyceride reductions with marine-derived fatty acid supplements, alongside LDL cholesterol increases in some low-dose groups. It examined how results varied by dose and duration, but the abstract does not establish an optimal regimen. Data were insufficient to pool several other metabolic outcomes, so broader health benefits remain uncertain.

Keep in mind: The abstract does not define the values following its ± symbols. Several outcomes lacked enough data for meta-analysis, and the conclusions make broader claims about those outcomes than the results can substantiate.

Testosterone changes did not differ significantly between the higher and standard vitamin D groups during follow-up. The analysis concerns a blood hormone measurement in breast cancer survivors. It does not prove the approaches equivalent, establish overall safety, or show how testosterone would change without supplementation, since both groups received vitamin D.

Keep in mind: The analysis was limited to women with complete measurements. The abstract gives no confidence interval for the between-group difference, which limits assessment of precision, and neither group served as an unsupplemented comparison.

Vitamin D supplementation was associated with lower mortality in patients with sepsis across the reported timeframes. Most included evidence came from cohort studies, so differences between patients could contribute to the association. The review rated the evidence as low certainty, leaving a causal survival benefit unconfirmed in these patients.

Keep in mind: Results varied substantially across studies, and certainty was rated low because of inconsistency and imprecision. The abstract does not describe comparison treatments or supplementation regimens.

The pooled analysis reports lower fasting glucose, HbA1c and insulin resistance, but the abstract does not identify the comparison treatments or follow-up duration. These marker changes do not establish fewer diabetes complications, and the computational analysis suggests possible mechanisms rather than demonstrating how the treatments worked in patients.

Keep in mind: The abstract does not specify the herbal preparations, doses, comparison treatments, study durations or adverse events. It also gives insufficient information to assess trial quality or consistency across the pooled studies.

Across randomized trials, ginger supplementation was associated with shifts in inflammatory and antioxidant markers, including lower C-reactive protein. These are laboratory outcomes: the abstract does not report whether people felt better or developed fewer health problems. The authors highlight substantial differences between studies, so the pooled results need cautious interpretation.

Keep in mind: High heterogeneity limits interpretation. The abstract provides no detailed participant breakdown, trial durations or comparator descriptions, and it does not report clinical outcomes.

Maternal vitamin D supplementation did not produce a statistically clear improvement in infants’ overall development compared with placebo. Language, movement, and cognitive scores also showed no clear differences. These findings concern the studied mothers living with HIV and their infants; they do not establish that the groups’ developmental outcomes were equivalent.

Keep in mind: Assessments were completed for 1312 of 2167 eligible infants. This abstract-based explanation cannot evaluate missing outcomes, and the findings concern caregiver reports at a single age.

Across all trials, probiotics improved HOMA-β, a model-based marker of pancreatic beta-cell function. However, restricting the analysis to trials judged at low risk of bias produced no statistically significant effect. This weakens confidence in the overall finding and does not establish benefits for symptoms, diabetes complications or long-term health.

Keep in mind: Results varied substantially across trials. The abstract does not report treatment durations or enough formulation details to connect the pooled estimates to a particular probiotic product.

Across the included trials, citrulline supplementation showed no substantial overall effects on body weight, body mass index, fat mass, waist size, body fat percentage or fat-free mass. Some subgroup results were favorable, but they do not establish that higher doses or shorter courses are better. The review therefore does not demonstrate an overall body-composition benefit.

Keep in mind: This abstract-based brief has no pooled effect sizes, confidence intervals or comparator details. The authors call for trials controlling diet and training, leaving subgroup patterns and long-term effects unresolved.

Curcumin improved liver fat, liver stiffness and a blood-sugar marker compared with placebo in this trial of people with obesity and diabetes. These are measurement-based outcomes, and the abstract does not report fewer liver complications or improved symptoms. Mild digestive discomfort occurred, while the reported safety testing found no clinically significant abnormalities.

Keep in mind: The abstract reports statistical significance without effect sizes or confidence intervals. It does not establish effects on liver complications, and findings from this specific clinical group should not be generalized to everyone.

Bacopa did not show greater improvement than placebo in verbal learning, attention or working memory. Some secondary measures of stress and fatigue favored the extract, but those signals need further study. Self-reported adverse reactions were more frequent with Bacopa, mainly digestive complaints and headaches, despite no serious reactions being reported.

Keep in mind: This abstract-based summary reflects results from 87 participants with complete data, rather than everyone randomized. The abstract gives no effect sizes or confidence intervals for the cognitive results, limiting assessment of their precision.

The report describes atrial flutter that appeared after a man started taking Tongkat Ali. The author considered the supplement a probable trigger because of the timing and the absence of identified alternative causes. This is a signal for further investigation, but a case report cannot establish that the supplement caused the rhythm disturbance.

Keep in mind: The abstract omits the supplement dose, exposure length and follow-up outcome. An isolated case without a comparison group cannot quantify risk or establish which ingredient, if any, was responsible.